| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.49▲ | 1.49▲ | 1.49▼ | 1.69▼ | 1.63▼ |
| MA10 | 1.48▲ | 1.50▼ | 1.53▼ | 1.70▼ | 1.50▼ |
| MA20 | 1.49▼ | 1.54▼ | 1.59▼ | 1.68▼ | 1.39▲ |
| MA50 | 1.52▼ | 1.66▼ | 1.71▼ | 1.49▼ | 2.08▼ |
| MA100 | 1.56▼ | 1.71▼ | 1.66▼ | 1.38▲ | 4.34▼ |
| MA200 | 1.69▼ | 1.66▼ | 1.61▼ | 1.49▲ | 5.99▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.002▲ | -0.009▼ | -0.025▼ | 0.119▲ |
| RSI | 46.571▼ | 31.747▼ | 27.227▼ | 43.500▼ | 46.100▼ |
| STOCH | 69.167 | 25.187 | 14.343▼ | 50.788 | 51.482 |
| WILL %R | -25.000▲ | -81.250▼ | -81.250▼ | -93.750▼ | -69.697 |
| CCI | 55.856 | -70.440 | -90.413 | -119.161▼ | 55.350 |
|
Thursday, May 22, 2025 02:30 AM
NEW YORK, May 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Actinium Pharmaceuticals, Inc. (NYSE: ATNM). Shareholders who purchased shares of ATNM ...
|
|
Thursday, May 08, 2025 03:45 PM
Inc. (NYSE:ATNM) securities between October 31, 2022 and August 2, 2024. Actinium is a late-stage biopharmaceutical company that develops targeted radiotherapies, such as Iomab-B, to treat people ...
|
|
Tuesday, April 29, 2025 09:26 PM
SAN DIEGO, April 30, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM).
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 1.58 | 1.615 | 1.46 | 1.49 | 489,200 |
| 12/06/25 | 1.63 | 1.687 | 1.56 | 1.59 | 271,500 |
| 11/06/25 | 1.77 | 1.795 | 1.65 | 1.66 | 247,800 |
| 10/06/25 | 1.94 | 1.94 | 1.68 | 1.755 | 532,153 |
| 09/06/25 | 1.85 | 1.94 | 1.80 | 1.94 | 316,400 |
| 06/06/25 | 1.69 | 1.85 | 1.65 | 1.83 | 336,400 |
| 05/06/25 | 1.72 | 1.73 | 1.63 | 1.69 | 191,700 |
| 04/06/25 | 1.67 | 1.73 | 1.64 | 1.71 | 141,200 |
| 03/06/25 | 1.65 | 1.69 | 1.57 | 1.68 | 198,735 |
| 02/06/25 | 1.55 | 1.63 | 1.54 | 1.62 | 254,595 |
|
|
||||
|
|
||||
|
|